Picibanil: Clinical Trials

6 trials of Picibanil, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 2 completed. 3 Phase 2, 2 Phase 1, 1 Not applicable, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Unknown 1
Phase 12Unknown 2
Not applicable1Unknown 1
Phase 31Completed 1
Phase 41Unknown 1

Follow Picibanil: new trials by email Literature Review of Picibanil trials Research Report on Picibanil

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy of OK-432 Pleurodesis on Postoperative Air Leak
OK-432 pleurodesis, normal saline pleurodesis - Postoperative Air Leak
Not applicableUnknownNational Taiwan University Hospital802015-07-012016-10-14
Cohort Prospective Study of Children With Head and Neck Cystic Malformation Who Are Treated With Intracystic OK432
Intracystic injection of OK432 under US guiding - CYSTIC MALFORMATION
Phase 4UnknownCarmel Medical Center52012-09-012013-12-02
Study of Chemo-Immunotherapy in Head and Neck Cancer Patients
Cyclophosphamide, Docetaxel, Dendritic cells, OK-432 - Head and Neck Cancer
Phase 1UnknownUniversity of Yamanashi102010-07-012011-08-24
OK432 (Picibanil) in the Treatment of Lymphatic Malformations
OK432 - Lymphatic Malformations
Phase 2CompletedRichard JH Smith2752005-10-052021-11-23
Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer
dendritic cells, OK-432 - Pancreatic Cancer
Phase 1 / Phase 2UnknownFukushima Medical University202003-11-012011-09-08
Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations
picibanil - Lymphatic Malformations
Phase 2 / Phase 3CompletedUniversity of Iowa1502000-04-012015-03-25

Conditions studied

Lymphatic Abnormalities (2)  ·  Head and Neck Neoplasms (1)  ·  Lymphangioma (1)  ·  Lymphangioma, Cystic (1)  ·  Pancreatic Neoplasms (1)

Sponsors

Carmel Medical Center (1)  ·  Fukushima Medical University (1)  ·  National Taiwan University Hospital (1)  ·  Richard JH Smith (1)  ·  University of Iowa (1)  ·  University of Yamanashi (1)

Countries

Japan (2)  ·  United States (2)  ·  Israel (1)  ·  Taiwan (1)

Top investigators

Jin-Shing Chen (1)  ·  Mitsukazu Gotoh, MD & PhD (1)  ·  Raanan Cohen-Kerem, MD (1)  ·  Richard J Smith (1)  ·  Richard JH Smith, MD (1)

Results publications

PMID 19117316